Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Return on Sales [ROS] (2009 - 2013)

Updated

Kazia Therapeutics' Return on Sales [ROS] was -53447.62% in FY2025 (year ended Jun 30, 2025).

Analysis

Kazia Therapeutics (KZIA) Return on Sales [ROS] (2009 - 2013) Analysis & Trends

From FY2009 onward, Kazia Therapeutics has reported Return on Sales [ROS] for 15 fiscal years.

  • Return on Sales [ROS] shows a five-year change of -52244.51 percentage points (FY2020 to FY2025).
  • The FY2025 figure marks the lowest annual Return on Sales [ROS] in data going back to FY2009.
  • Per Business Quant data, Return on Sales [ROS] in earlier fiscal years was -1171.97% in FY2024 and -58.64% in FY2021 (+1144.47 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 24.35%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 36.01%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 30.74%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 29.12%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 35.79%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 41.71%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 32.98%
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -87.17%
Aug 30, 2013 -167.18%
Dec 31, 2012 -61.99%
Dec 31, 2011 1,187.45%
Dec 31, 2010 891.05%
Dec 31, 2009 -10.39%
API Access

Kazia Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=KZIA&period=max&api_key=YOUR_API_KEY